We describe herein an approach for the specific enrichment of linear polyUb-modified substrates, which enabled us to identify novel linear polyUb targets, including ATR, BRAP, LGALS7, PLAA, SEPT2, HDAC6, VDAC1 and TRAF6. Moreover, we demonstrated that linear polyubiquitination of TRAF6 is essential for proper IL-1β-dependent NFκB signaling.
ubiquitination controls a plethora of cellular processes. modifications by linear polyubiquitin have so far been linked with acquired and innate immunity, lymphocyte development and genotoxic stress response. until now, a single e3 ligase complex (luBAc), one specific deubiquitinase (otulin) and a very few linear polyubiquitinated substrates have been identified. current methods for studying lysine-based polyubiquitination are not suitable for the detection of linear polyubiquitin-modified proteins. here, we present an approach to discovering linear polyubiquitin-modified substrates by combining a lysine-less internally tagged ubiquitin (intub.7Kr) with silAc-based mass spectrometry. We applied our approach in tnF-stimulated t-rex heK293t cells and validated several newly identified linear polyubiquitin targets. We demonstrated that linear polyubiquitination of the novel luBAc substrate trAF6 is essential for nFB signaling.
Post-translational modification by ubiquitin (Ub) regulates fundamental cellular processes, including protein stability, DNA repair, inflammation and immune response 1, 2 . In addition to mono-and multiple monoubiquitination, all seven internal Ub lysine (K) residues can form K-specific Ub linkages, thus forming polyUb chains with distinct structures, assembly machineries and functions in the cell 3 . Additionally, the N-terminal methionine (M) of Ub can form a peptide bond with the terminal glycine (G) of another Ub moiety, generating linear polyUb chains 4 .
Although its basal cellular levels are very low 5, 6 , linear polyubiquitination can be rapidly induced in the cell, eliciting a specific cellular response to a given stimulus. These stimuli include TNFα 7 , heat stress response 8 and bacterial infection 9 , with linear polyubiquitination being crucial in inducing inflammatory, acquired and innate immune responses 10 , genotoxic stress response and Parkinson's disease 11 . Additionally, numerous cellular processes require timely regulated and coordinated activation of linear polyubiquitination, such as survival of mature T cells 12 , late thymic T-cell differentiation 13 and B-cell development and activation 14 . The only known E3 ligase complex that generates linear polyUb chains is the linear ubiquitin assembly complex (LUBAC), which consists of three proteins: catalytic subunit RNF31 (HOIP) 15, 16 , RBCK1 (HOIL-1L) and SIPL1 (SHARPIN) [17] [18] [19] . OTULIN (FAM105B or GUMBY) is the main deubiquitinating enzyme (DUB) highly specific for linear Ub chains 20, 21 .
Only a handful of linear polyUb-modified substrates have been identified so far 7, 18, [22] [23] [24] , including K63-linked polyUb chains, which serve as a substrate for the generation of mixed, K63-M1 hybrid polyUb linkages 25 . Nevertheless, these few proteins (including NEMO) have already been linked with several severe diseases, such as X-linked anhidrotic ectodermal dysplasia with immunodeficiency (XR-EDA-ID) [26] [27] [28] , justifying the need for a method to identify novel linear polyUb targets and processes in which they play a role.
A widely used approach for the identification of ubiquitinated proteins is Ub remnant profiling [29] [30] [31] . Unfortunately, GGK-specific monoclonal antibodies [29] [30] [31] do not recognize the characteristic GGMQIFVK signature peptides (in which underlining indicates the conjugation site on linear ubiquitin) resulting from tryptic cleavage of linear polyubiquitin. Other existing methods also cannot identify linear polyubiquitination substrates. N-terminally tagged Ub constructs [32] [33] [34] prevent linear polyUb chain assembly due to the requirement for a free M1 residue to build linear polyUb chains. The use of tandem linear polyUbbinding domains (UBDs) for enriching linear polyUb chains is limited to mild cellular lysing conditions, leading to high background in mass spectrometry (MS) analyses and resulting in a large number of false-positive hits. An additional disadvantage of linear UBDs is that they can also bind K63-linked Ub chains to a certain extent. The two currently available linear polyUb-specific antibodies are not optimal. The Genentechgenerated antibody 1F11/3F5/Y102L can, to a certain extent, recognize and capture K63-linked polyUb chains 5 , while the Lub9 antibody is not suitable for immunoprecipitation (IP) experiments, thus it can only be used to confirm putative linear polyUb targets 14 . can form various polyUb chains ( Fig. 1c and Supplementary  Fig. 1d,e) . Additionally, INT-Ub can bind UBDs that recognize single Ub moieties ( Supplementary Fig. 1f) ; the internal tag did not affect the ability of linear diUb to bind to linear polyUb-specific UBD (ubiquitin binding in ABIN and NEMO, UBAN) 35 ( Fig. 1d and Supplementary Fig. 1g) . Moreover, recombinant INT-diUb could be cleaved by Ub-chain-unspecific DUB fragment USP2-cc ( Fig. 1e and Supplementary Fig. 1h ) 36 and linear polyUb-specific DUB OTULIN ( Fig. 1f and Supplementary Fig. 1i ).
evaluation of internally tagged ub functionality in vivo
We generated T-REx HEK293T and T-REx HeLa cell lines inducibly expressing small amounts of wild-type INT-Ub, INT-Ub.7KR or INT-Ub.∆GG mutants in order to ensure that INT-Ub variants were present only as minor fractions of the total cellular Ub pool (Supplementary Fig. 2a ). As shown in Figure 2a (Fig. 2b) . Moreover, we demonstrated that pulled-down INT-Ub, unlike INT-Ub.∆GG, is enriched in ubiquitinated substrates by detecting endogenous PCNA-associated factor of 15 kDa (PAF15), which is known to be monoubiquitinated and double monoubiquitinated 37 (Fig. 2c) .
It was also important to determine whether INT-Ub variants, particularly INT-Ub.7KR, perturb cellular functions. As a model process, we chose the NFκB signaling pathway, since it is highly regulated by ubiquitination, with linear polyubiquitination of NEMO being crucial for NFκB activation 7, 18 . Upon TNFα stimulation, expression of INT-Ub variants did not affect nuclear translocation of NFκB dimers compared with the empty vector control (Fig. 2d,e) . Additionally, we did not observe any significant difference in the transcriptional activity of NFκB in any cell line, except for INT-Ub.∆GG ( Fig. 2f and Supplementary Fig. 2b) siRNA ( Fig. 3a) , catalytic-inactive OTULIN mutant C129A (Fig. 3b) or HOIP/HOIL-1L (Fig. 3c) , as well as TNFα treatment (Fig. 3d) in doxycycline-induced INT-Ub.7KR T-REx HEK293T cells. In all the cases, the amount of pulled-down HMW Ub species was increased compared to control conditions ( Fig. 3a-d) .
Furthermore, samples with transiently transfected OTULIN C129A mutant had increased amounts of HMW STREP-tag-IIcontaining species, indicating the enrichment of INT-Ub.7KR (Fig. 3e) . To verify that the HMW Ub species indeed contained linear polyUb, samples were immunoblotted with the Lub9 antibody ( Fig. 3f and Supplementary Fig. 2c ), further confirming the presence of linear polyUb-modified substrates. Moreover, we demonstrated the presence of HMW species of the known LUBAC substrate NEMO in INT-Ub.7KR pull down (PD) ( Supplementary  Fig. 2d ) upon TNFα treatment, confirming that INT-Ub.7KR enables enrichment of linear polyUb-modified proteins.
identification of novel linear polyubiquitin targets
For our MS screen, we chose TNFα stimulation as the wellestablished physiological stimulus 7, 38 for the induction of linear polyubiquitination ( Fig. 4a and Supplementary Fig. 3a ). For the initial MS experiment, cells were treated with TNFα for 15 min (Supplementary Table 1 ). Because of the relatively low SILAC ratios in the MS screen ( Supplementary Fig. 3b ), we further optimized the procedure by modifying lysis/PD buffer, by replacing Strep-Tactin with the third generation of Strep-Tactin XT resins (IBA) as well as by generating a new set of SILAC-labeled T-REx HEK293T cell lines expressing INT-Ub variants. The time of TNFα stimulation was decreased to 10 min for optimal induction of linear polyubiquitination 39 . MS measurements of three independent experimental replicates quantified a total of 1,695 protein groups at FDR of 1% at protein and peptide level (Supplementary Table 2 As expected, KEGG and GOMF annotation enrichment analyses showed significant over-representation of Ub-related processes and proteins, further confirming that INT-Ub variants are functional (Fig. 4b,c) . Interestingly, protein functions related to systemic lupus erythematosus, an autoimmune disease recently linked with linear polyubiquitination and LUBAC 40 , were significantly enriched. Moreover, the MS data set showed statistically significant over-representation of proteins linked with Parkinson's disease. The E3 ligase PARKIN has already been linked with inflammation and shown to interact with LUBAC to regulate both LUBAC activity 41 and its recruitment to the mitochondria, resulting in abrogated IFNβ production 42 . Therefore, KEGG enrichment analysis indirectly suggests that the MS data set was indeed enriched in linear polyUb-modified proteins.
The putative linear polyUb-modified substrate selection was focused on proteins preferentially present in INT-Ub (L) and INTUb.7KR (M) SILAC-labeled inducible T-REx HEK293T cells, in comparison to INT-Ub.∆GG (H) SILAC-labeled cells (which were used as a negative MS control) ( Fig. 4d and Supplementary Table 2) . Since both INT-Ub and INT-Ub.7KR could be incorporated into linear polyUb chains, the INT-Ub/INT-Ub.7KR (L/M) ratio was considered as the supporting selection criterion. For the validation of the INT-Ub approach, we chose several candidates with SILAC ratios equal to or above 2 such as ATR, BRAP, LGALS7 and PLAA. To test the sensitivity of our method, we also included several proteins found near MS background in both preliminary and triplicate MS experiments, such as SEPT2, HDAC6, VDAC1 and TRAF6 (this last protein was identified only in the preliminary MS screen on account of much lower expression level in the second set of T-REx HEK293T cell lines) (Supplementary Fig. 3d ). 
Validation of putative linear polyubiquitin-modified substrates
Since there is no well-established method for confirming modification by linear polyUb, we performed several complementary approaches to validate novel substrates. For our MS screens we used TNFα to induce linear polyubiquitination. We reasoned that, even if additional, unidentified linear polyUb-specific E3 ligases existed in the cell, we would preferentially identify LUBACdependent substrates.
First, for the majority of selected MS candidates, we observed HMW species migrating above protein bands, both on total cell lysate (TCL) level and upon IP, only in the presence of the active LUBAC complex, indicative of (presumably linear) polyubiquitination. No HMW species were observed when catalytic-dead LUBAC (HOIP C885A and HOIL-1L) was used ( Supplementary Fig. 4a and data not shown). Furthermore, we showed that candidates for which we could purify MBP or GST fusions of sufficient quality could bind overexpressed LUBAC subunits HOIP and Fig. 4b) . Next, we utilized the recombinant tandem of three NEMO UBAN domains (superUBAN) to pull down linear polyUb-modified substrates. Upon LUBAC overexpression, the amount of HMW HA-tagged TRAF6 pulled down with the superUBAN was significantly increased, while the HMW species of the other HA-tagged substrates only bound to superUBAN when LUBAC was coexpressed (Fig. 5a) . Binding to HMW Ub species of putative substrates was specific, since it was abolished when NEMO Ub-binding-deficient mutant F305A (superUBAN F305A) was used (Fig. 5a) . Moreover, we observed linear polyUb HMW species above all the HA-and MYC-tagged putative LUBAC substrates when we immunoprecipitated them under denaturing conditions from the samples with ectopically expressed LUBAC complex (Fig. 5b) . Furthermore, we used 1F11/3F5/Y102L antibody 5 to immunoprecipitate linear polyUb-modified proteins under denaturing conditions from the samples containing overexpressed active LUBAC. We detected HMW species above substrates with anti-HA antibody, strongly indicating linear polyubiquitination of putative LUBAC substrates (Fig. 5c) . Moreover, we performed an in vitro ubiquitination assay with recombinant active LUBAC and recombinant candidates. TRAF6 is an adaptor protein and E3 ligase that generates K63-linked polyUb chains and ubiquitinates itself as well as several proteins, including NEMO and AKT1 43, 44 . Deacetylase HDAC6 has also been suggested to possess intrinsic E3 ligase activity 45 . Thus, an additional control was applied for TRAF6 and HDAC6. We observed that SEPT2, HDAC6, VDAC1 and TRAF6 are polyubiquitinated by LUBAC in vitro (Supplementary Fig. 4c) . Also, the observed increase of wild-type TRAF6 ubiquitination in the presence of LUBAC was decreased when sample was additionally treated with active OTULIN (Supplementary Fig. 4d) , further confirming TRAF6's linear ubiquitination.
HOIL-1L (Supplementary
We analyzed the TRAF6 sample (from Fig. 5b ) by MS and identified the characteristic linear polyUb peptide GGMQIFVK ( Supplementary Fig. 4e and Supplementary Table 1) . As the final proof, we immunoprecipitated linear polyUb-modified proteins under denaturing conditions from the samples containing ectopic LUBAC complex and detected HMW species of several endogenous putative substrates (Supplementary Fig. 4f) .
the functional significance of trAF6 linear polyubiquitination
Despite relatively low enrichment of TRAF6 in the MS screen, TRAF6 proved to be a very potent MS candidate during the evaluation of putative linear polyUb-modified substrates. Therefore, we hypothesized that TNFα (originally used in our MS experiment) might not be the optimal physiological stimulus for the linear polyubiquitination of TRAF6. Since TRAF6 is involved in IL-1β-dependent NFκB signaling 46 , we compared the ability of IL-1β with that of TNFα to induce linear polyubiquitination of TRAF6. Our data show that IL-1β-dependent linear polyubiquitination of TRAF6 is stronger than the one induced by TNFα (Fig. 6a) . When we additionally silenced HOIP expression by siRNA approach, IL-1β failed to induce linear polyubiquitination of TRAF6 (Supplementary Fig. 5a ), confirming that LUBAC modifies TRAF6 with linear polyUb chains.
Next, we tested whether E3 ligase activity of TRAF6 is a prerequisite for its linear polyubiquitination. We found that recombinant catalytically inactive TRAF6 C70A mutant is also modified by LUBAC (Fig. 6b) . Thus, TRAF6 E3 ligase activity is not required for its subsequent linear polyubiquitination, as LUBAC directly modifies TRAF6 by linear polyUb chains. By MS, we identified three K-residues of TRAF6 ubiquitinated upon LUBAC overexpression, one within a coiled-coil motif that was previously reported (K339 31 ) and two novel sites within the MATH domain (K497 and K518) (Fig. 6c, Supplementary Fig. 5b and Supplementary  Table 1) . Interestingly, K339 and K497 are conserved among species, suggesting their physiological significance. When we tested the ability of recombinant TRAF6 C70A and TRAF6 C70A K339 K497 K518R (K339,497,518R) mutants to be modified by LUBAC in vitro (Supplementary Fig. 5c,d) , triple K339,497,518R TRAF6 mutant was not ubiquitinated. Similarly, immunoprecipitated TRAF6 K339,497,518R mutant could not be efficiently modified by linear polyUb chains upon IL-1β stimulation (Fig. 6d) , confirming that the identified residues of TRAF6 are the major targets for LUBAC-mediated polyubiquitination.
To further study the importance of linear polyubiquitination of TRAF6 in the NFκB pathway, we tested phosphorylation and degradation of IκBα (Supplementary Fig. 5e ) as well as NFκB transcriptional activity (Fig. 6e) in TRAF6 −/− MEFs reconstituted with various TRAF6 mutants (Supplementary Fig. 5f ). As expected, degradation of IκBα in IL-1β-stimulated TRAF6 −/− MEFs reconstituted with either empty vector or TRAF6 C70A was abolished, confirming the crucial role of TRAF6 E3 ligase activity in IL-1β-induced NFκB signaling. Reconstitution of TRAF6 −/− MEFs with wild-type TRAF6 restored phosphorylation and degradation of IκBα. Interestingly, TRAF6 −/− MEFs reconstituted with TRAF6 K339,497,518R mutant could activate the NFκB pathway but could not sustain the activating effect on the pathway. Expression of TRAF6 K32-518R mutant also resulted in impaired IκBα degradation. The effect of both TRAF6 K-deficient mutants on NFκB transcriptional activity is even more striking, as both TRAF6 K339,497,518R and TRAF6 K32-518R inhibit IL-1β-induced NFκB activity. Therefore, both TRAF6 E3 ligase activity and its linear polyubiquitination are essential for proper IL-1β-induced NFκB signaling. discussion Knowledge about the recently discovered linear polyUb modification is limited by a lack of adequate methods that permit identification of linear polyUb-modified proteins. Here, we introduce a K-less internally tagged Ub tool, combined with MS analysis, to identify linear polyUb targets in a simple and robust manner.
Ub is a rather small, highly conserved eukaryotic protein, and the majority of its surfaces are required for the interaction with Ub machinery (E1, E2, E3, DUB) or UBD-containing proteins. Nevertheless, our choice of the insertion point and insertion tag within Ub fully maintains the structural and functional integrity of Ub both in vitro and in vivo.
We have identified several novel linear polyUb-modified proteins, significantly expanding the number of known linear polyUb targets. Since proteins found near the MS background (i.e., TRAF6 and VDAC1) were also shown to be modified by linear polyUb chains, our INT-Ub.7KR approach represents a sensitive method for the discovery of linear polyUb-modified proteins. The major limitations of our approach are related to MS detection sensitivity, as well as the low abundance of linear polyUb targets in tested cell lines. Typically, only a small pool of the protein is modified by linear polyUb chains. If the protein is expressed at low levels, MS signals from modified proteins with very low abundance will be close to noise levels and will not have high SILAC ratios.
The E3 ligase complex LUBAC is so far the only enzyme known to generate linear polyUb chains. Nevertheless, the INT-Ub.7KR approach enables identification of both LUBAC-dependent and even LUBAC-independent linear ubiquitination, since it does not rely on using LUBAC during the screen. By combining INTUb.7KR with other stimuli (such as DNA damage-inducing compounds, heat shock, various pathogen infections) it will be possible to identify stimulation-specific linear polyubiquitination substrates (and in this way, novel processes regulated by linear polyubiquitination), both LUBAC dependent and (potentially) LUBAC independent. Since INT-Ub.7KR maintains the Ub fold and does not lead to cellular toxicity when expressed at low levels, the generation of knock-in animal models would enable the study of linear polyubiquitination during development and its cellular roles in both normal and pathological conditions. Moreover, the identification of novel linear polyUb targets, beyond a handful of known proteins 7, 18, [22] [23] [24] , will hopefully enable the development of targeted therapy for diseases caused by impaired linear polyubiquitination.
Overall, our INT-Ub.7KR approach should contribute to the understanding of the largely underestimated spectrum of linear polyubiquitination, expanding the current view of its cellular roles. methods Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. Cell lines. Cell lines HEK293T, T-REx HEK293T (T-REx-293) and T-REx HeLa (T-REx-HeLa) were purchased, respectively, from ATCC and Invitrogen. Early passages were propagated and frozen at −150 °C, and aliquots were used for a limited number of passages. TRAF6 −/− MEFs were obtained from J.-I. Inoue (University of Tokyo). All cells were regularly checked for Mycoplasma infection using VenorGeM Classic from Minerva Biolabs GmbH (Ltd.).
Purification of MBP-, GST-, HIS-and STREP-tag protein fusions.
Various MBP and GST fusions were purified as previously shown 47 . STREP-tag INT-Ub proteins were purified according to Qiagen's protocol. Briefly, a bacterial pellet was thawed and resuspended in buffer NP (50 mM NaH 2 PO 4 and 300 mM NaCl; pH 8.0) together with 1 mg/ml lysozyme and 3 U/ml benzonase. After incubation on ice (30 min) lysate was sonicated, centrifuged (10,000× g for 20 min, 4 °C) and supernatant incubated with StrepTactin Sepharose (IBA, 1 h, 4 °C with rotation). INT-Ub proteins bound to Strep-Tactin Sepharose were washed with buffer NP and eluted with buffer NPD (50 mM NaH 2 PO 4 , 300 mM NaCl and 2.5 mM desthiobiotin; pH 8.0). Proteins for structural characterization by CD-spectroscopy were further purified by size exclusion chromatography using a Superdex S75 column (GE Healthcare) in 50 mM HEPES (pH 7.4) and 150 mM NaCl. Fractions of highly pure Ub variants were identified by SDS-PAGE and subsequently concentrated using Vivaspin Protein Concentrators (GE Healthcare). The proteins GST-UBE2S-UBD, GST-AMSH, GST-NIeL, GST-CBL RF, MBP-HOIP RBR-C and 6xHIS-USP2-cc were purified as previously described 36, [48] [49] [50] [51] [52] . After purification, UBE2S-UBD, OTULIN and NIeL were then respectively cleaved with PreScission (GE Healthcare) and TEV (Invitrogen) proteases to remove GST moiety. HOIL-1L/HOIP-6xHIS, 6xHIS-SEPT2, 6xHIS-VDAC1 and 6xHIS-TRAF6, in addition to its mutants, were purified as previously described 23 .
GST and MBP pull-down assays. HEK293T cells were transiently transfected with indicated plasmids using GeneJuice (Merck Millipore). 24-48 h post-transfection cells were lysed in a lysis buffer (50 mM HEPES, pH 7.5; 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10 mM ZnCl 2 , 10% glycerol, 1% Triton X-100, 25 mM NaF, 2 mM NEM, 1 mM PMSF and complete protease and phosphatase inhibitors (Roche)). Cell lysates were incubated with either GST-or MBP-fused proteins bound, respectively, to glutathione sepharose beads or amylose resin. After overnight incubation, samples were washed three times in a lysis buffer and eluted from resins by incubation in a 1× LDS buffer supplemented with β-mercaptoethanol (10 min, 70 °C). To test direct interactions, either eluted or cleaved recombinant GST-or MBPtagged proteins were incubated, respectively, with MBP-or GSTfused proteins bound to amylose resin or glutathione sepharose resin in an incubation buffer (20 mM Tris-HCl, pH 8.4; 150 mM NaCl, 2.5 mM CaCl 2 , 10% glycerol, 1% Triton X-100 and 1 mM DTT) at 4 °C. After 4 h incubation, samples were washed three times in an incubation buffer and eluted from resins by incubation in a 1× LDS buffer supplemented with β-mercaptoethanol (10 min, 70 °C).
SuperUBAN pull-down assays. The assay was modified from ref. 23 . Briefly, GST-tagged superUBAN (UBANx3) and superUBAN F305A (UBANx3 F305A) were purified as described above. HEK293T cells were transfected with indicated constructs using GeneJuice. 24 h post-transfection cells were lysed in a pull-down buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl, 1% NP-40, 0.5% DOC, 10 mM NEM and complete protease and phosphatase inhibitors (Roche)), sonicated for 20 s at 10% and treated with benzonase. Protein concentrations were measured and adjusted, and lysates were then precleared with GST protein bound to glutathione sepharose resins (1 h, 4 °C with rotation). Cleared lysates were then incubated with GST, GST UBANx3 or GST UBANx3 F305A bound to glutathione sepharose (overnight, 4 °C with rotation). Samples were washed three times in a pulldown buffer and eluted from resins by incubation in a 1× LDS buffer supplemented with β-mercaptoethanol (10 min, 70 °C). In cases where samples were prepared for MS analysis, they were additionally washed twice in ddH 2 O supplemented with 2 mM NEM before elution.
In vitro ubiquitination reaction. The enzymes 6xHIS-E1, UBCH5a, UBCH5c, 6xHIS-UBC13/UEV1 (all Boston Biochem) and UBCH7 (Merck Millipore) were purchased. MBP-HDAC6 was purified as described above followed by overnight cleavage with factor Xa at room temperature. Reactions contained 200 ng E1, 400 ng UBCH5c, 1 µg purified HOIL-1L/HOIP-6xHIS, 1 µg 6xHIS-SEPT2, 1 µg 6xHIS-VDAC1, 2 µg MBP-HDAC6, 1 µg 6xHIS-TRAF6 variant, 10 µg Ub, 2 mM ATP, 20 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 and 2 mM DTT. The assay was performed at 37 °C for 3 h and stopped by adding a 1× LDS buffer supplemented with β-mercaptoethanol. Reactions with UBE2S-UBD and AMSH, NIeL, CBL RF, HOIP RBR-C and USP2-cc were performed as previously described 36, [48] [49] [50] [51] . All the other reactions were performed by incubating E1 (150 ng), E2 (300 ng), E3 (2 µg), Ub or INT-Ub variants (1 µg) with or without 2 mM ATP in in vitro ubiquitination buffer (50 mM Tris-HCl, pH 7.5; 5 mM MgCl 2 , 2 mM DTT) for 1 h at 37 °C. To stop reactions, a 1× LDS buffer supplemented with β-mercaptoethanol was added.
Deubiquitinase assays. Reactions with USP2-cc and OTULIN were performed as described previously 36, 53 .
CD measurements. Far-UV CD spectra were recorded on a Jasco J-815 spectropolarimeter fitted with a cell holder thermostatted by a CDF-426S Peltier unit. All CD measurements were made in 50 mM sodium phosphate buffer (pH 7.4) at 20 °C using fused silica cuvettes with 1 mm path lengths (Hellma, Jena, Germany). The spectra were recorded with 0.2 nm resolution and baseline corrected by subtraction of the appropriate buffer spectrum. CD intensities are presented as the CD absorption coefficient calculated on a mean residue weight basis (∆ε MRW ) 54 . In order to visualize the overlapping shape of all four Ub variants, the spectra of INT-Ub.7KR were multiplied by 1.3, which accounts for a slight overestimation of the protein concentration.
Nuclear magnetic resonance spectroscopy. All measurements were performed at 293 K in 20 mM HEPES (pH 7.4), 50 mM NaCl, 10% D 2 O on a Bruker AV600 spectrometer. When kept in medium containing zeocin (300 µg/ml) and blasticidin (10 µg/ml), INT-Ub expression was silenced.
Strep-Tactin pull down. A Strep-Tactin pull down was performed as follows: stable T-REx HEK293T cell lines were either transfected and/or treated as indicated in the text, and expression of various INT-Ub mutants was induced by doxycycline treatment (1 µg/ml; 24 h). Cells were lysed in either a denaturing buffer (20 mM Tris-HCl, pH 7.5; 50 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.5% SDS, 0.5% sodium deoxycholate, 1 mM DTT, 10 mM NEM and a 1× protease inhibitor cocktail) or a modified denaturing buffer (lacking DOC). Cells harvested in a modified denaturing buffer were additionally sonicated for 35 s at amplitude 40%. After benzonase treatment, protein concentration was adjusted and samples precleared with Superflow resin (IBA, 30 min, 4 °C). Precleared lysates were incubated with prewashed Strep-Tactin resins (2 h, 4 °C) and then subjected to three washing steps in a denaturing buffer. Finally, proteins were eluted by incubation in a 1× LDS buffer supplemented with β-mercaptoethanol (10 min, 70 °C).
Immunoprecipitation. HA-IP was performed as Strep-Tactin PD, with the exception that anti-HA agarose conjugate was used. Linear Ub IP was performed as described previously 5 . Additionally, linear Ub IP samples were washed twice with ddH 2 O supplemented with 10 mM NEM before elution in a 1× LDS buffer supplemented with β-mercaptoethanol (10 min, 70 °C). MYC-IP was performed similar to Strep-Tactin PD, with the exception that cells were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.5; 150 mM NaCl, 1% NP-40, 0.5% SDS, 0.5% sodium deoxycholate, 10 mM NEM and a 1× protease inhibitor cocktail), and lysates were subsequently incubated with 0.25 µg of c-Myc antibody and protein G agarose.
Immunoblotting. For all the experiments apart from linear Ub IP, immunoblotting was performed as follows: proteins were separated by SDS-PAGE and transferred to either 0.45 µm or 0.22 µm nitrocellulose membrane by wet transfer (200 mA, 2 h). Membranes were blocked either in 5% BSA in TBS-T or in 5% milk in TBS-T and probed with indicated primary antibodies overnight at 4 °C or for 1 h at RT. Next, membranes were washed in TBS-T, incubated in an appropriate HRP-conjugated secondary antibody for 1 h at RT and washed three times in TBS-T and then twice in TBS. Western Blotting Luminol reagent (Santa Cruz Biotechnologies) or Lumigen TMA-6 (GE Healthcare) were used for antibody visualization. To visualize linear polyubiquitin fraction, immunoblotting was performed as previously described 5 .
For linear Ub IP, endogenous levels of modified proteins were visualized with Clean-Blot IP Detection Reagent (Thermo Fisher Scientific). Full blots for the main text figures are available in Supplementary Figures 6-11 . Full blots for the Supplementary  Figures 1-5 are available in Supplementary Figures 12-15 .
Preparation of samples for mass spectrometry analysis. An expression of various INT-Ub variants was induced by doxycycline (1 µg/ml; 24 h) and followed by 16 h starvation in a medium lacking fetal bovine serum (FBS). For preliminary MS experiments, cells were stimulated with TNFα (20 ng/ml, 15 min) and harvested in a denaturing buffer (20 mM Tris-HCl, pH 7.5; 50 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.5% SDS, 0.5% sodium deoxycholate, 1 mM DTT, 10 mM NEM and a 1× protease inhibitor cocktail (Roche)) After benzonase treatment, lysates were precleared with prewashed Superflow resins (30 min, 4 °C). Protein concentration was measured, and lysates were merged in 1:1:1 ratio, followed by incubation with prewashed Strep-Tactin resins (2 h, 4 °C). Resins were then washed three times in a denaturing buffer and then twice in distilled water. Bound proteins were eluted from the Strep-Tactin resin by incubation in a 1× LDS buffer supplemented with β-mercaptoethanol (10 min, 70 °C). In the case of the additional triplicate MS experiment, the following changes were introduced: cells were stimulated with TNFα for 10 min and then lysed in a modified denaturing buffer (lacking DOC). Precleared lysates were incubated with prewashed StrepTactin XT resins (IBA).
Mass spectrometric analysis.
Eluates obtained from Strep-Tactin resins were resolved by SDS-PAGE, each gel lane was cut into 8-15 slices, alkylated with chloroacetamide and digested with trypsin (overnight, 37 °C) 55 . Extracted peptides were desalted using C 18 StageTips 56 . A preliminary MS screen of linear polyUbmodified substrates was performed on an EASY-nLC II (Proxeon Biosystems) System coupled to an Orbitrap Elite (Thermo Fisher Scientific) mass spectrometer. Peptides were separated on a 15 cm and 75 µm ID PicoTip fused silica emitter (New Objective) inhouse packed with ReproSil-Pur C18-AQ 3 µm resin (Dr Maisch GmbH (Ltd.)). Peptides were eluted from the column using a segmented gradient of 5-50% of solvent B (80% ACN in 0.5% acetic acid) at a constant flow rate of 200 nL/min over 87 or 127 min. The mass spectrometer was operated in positive ion mode, and spectra were recorded in a mass range from m/z 300 to 2,000 with a resolution of 120,000. The 20 most intense ions were selected for collisional-induced dissociation (CID) fragmentation. For targeted MS inclusion lists containing up to 115 peptide masses of interest (ubiquitinated TRAF6 peptides and Ub peptides including modifications and GGM peptide) were exclusively selected for HCD fragmentation and MS/MS acquisition (R = 15,000). Additional MS screening for the identification of novel linear polyUb targets was performed on an EASY-nLC 1200 System (Thermo Fisher Scientific) coupled to a Q Exactive HF (Thermo Fisher Scientific) mass spectrometer. Peptides were separated using a segmented gradient of 5-50% of solvent B (80% ACN in 0.5% formic acid) at a constant flow rate of 200 nL/min over 87 min on a 20 cm and 75 µm ID PicoTip fused silica emitter (New Objective) in-house packed with ReproSil-Pur C18-AQ 1.9 µm resin (Dr Maisch GmbH (Ltd.)). The Q Exactive HF was operated in positive mode. Full scans were acquired from m/z 300 to 1,650 with a resolution of 120,000. The seven most intense ions were fragmented by higher energy collisional dissociation (HCD) and MS/MS spectra recorded with a resolution of 60,000. Experiments were performed in triplicate. Obtained mass spectra were processed with the MaxQuant 57 software suite (version 1.5.1.0) using the internal search engine Andromeda 58 and searched against either the Uniprot Homo sapiens (release 2014_02; 88,692 entries) database and a database containing INT-Ub and INT-Ub.7KR sequences or the Mus musculus (release 2014_02; 51402 entries) database. Carbamidomethylation (C) was set as fixed modification and acetylation (protein N-term), oxidation (M), GlyGly (K, Nterm), deamidation (N, Q) were defined as variable modifications. In SILAC measurements, the amino acids K4/R6 and K8/R10 were defined as medium and heavy labels, respectively. Mass tolerance at the MS level was set to 4.5 p.p.m. and to 0.5 Da at the MS/MS level (CID fragmentation), or 20 p.p.m. (HCD fragmentation). The false discovery rate for peptides and proteins was set to 1%. An arbitrary cutoff of two-fold change was used to determine significant SILAC ratios. A functional enrichment analysis (Fisher's exact test, P < 0.01) of GO and KEGG terms was performed in Perseus (version 1.5.0.15) 59 .
siRNA silencing. The following siRNAs (Eurofins Genomics) were used for knockdown: OTULIN1# GAC UGA AAU UUG AUG GGA A; OTULIN2# CAA AUG AGG CGG AGG AAU A; Hoip GAG GAC GGA GUU GUG AGG AUU UCC A and mock GGG AUA CCU AGA CGU UCU A. Knockdown studies were conducted as previously described 19 . Subcellular fractionation. Cells were washed once with ice-cold PBS, resuspended in 100 µl ice-cold buffer A (10 mM HEPES, pH 7.8; 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, 5 µg/ml aprotinin, 2 µM pepstatin, 10 µg/ml leupeptin, 1 mM PMSF, 5 mM NaF, 1 mM Na 3 VO 4 and 0.5% Triton X-100), incubated on ice for 10 min and then centrifuged (2,000 r.p.m., 5 min, 4 °C). A supernatant was designated the cytoplasmic fraction. The pellet was then washed twice in ice-cold buffer A and resuspended in a 30 µl buffer C (50 mM HEPES, pH 7.8; 420 mM KCl, 0.1 mM EDTA, 5 mM MgCl 2 , 10% glycerol, 1 mM DTT, 5 µg/ml aprotinin, 2 µM pepstatin, 10 µg/ml leupeptin, 1 mM PMSF, 5 mM NaF and 1 mM Na 3 VO 4 ). After 30 min incubation on ice, the pellet was passed several times through a syringe and centrifuged (13,000 r.p.m., 15 min, 4 °C). The supernatant was designated the nuclear fraction.
Luciferase assays. Cells were plated on six-well plates 24 h before transfection. pNFκB-Luc plasmid and β-Gal plasmid were transfected using either GeneJuice (T-REx HeLa stable cell lines) or TurboFect (reconstituted TRAF6 −/− MEFs). 24 h post-transfection, cells were moved to medium lacking FBS for 16 h and then stimulated with either IL-1β (10 ng/ml) or TNFα (20 ng/ml) for indicated times. Cell lysates were subjected to a luciferase assay according to the manufacturer's protocol (Roche). Internal control was measured by β-Gal activity following the manufacturer's protocol (Roche). All experiments were done in biological triplicates, where each biological triplicate consisted of technical duplicates. Retroviral production. Untagged Ub and INT-Ub variants in pBabezeocine and HA-tagged mTRAF6 variants in pBabe-puromycin plasmids together with helper plasmid pHAI were transfected in HEK293T cells by using GeneJuice (Merck Millipore). 36 h posttransfection, media containing retroviruses were filtered, polybrene (4 mg/ml) was added and target cells (Ub variants into T-REx HEK293T/T-REx HeLa and TRAF6 mutants into TRAF6 −/− MEFs) were infected. 48 h later cells were selected with medium containing either zeocine and blasticidin (Ub variants, 300 µg/ml and 10 µg/ml, respectively) or puromycin (TRAF6 mutants, 4 µg/ml) and kept in medium containing appropriate antibiotic(s). Figures 2e,f and 6e and Supplementary Figure 2b , an unpaired, two-tailed Student's t test was used. Three independent experimental replicates were performed in Figure 2e . Three independent experimental replicates consisting of three technical replicates were performed in Figure 2f and Supplementary Figure 2b . Four independent experimental replicates consisting of three technical replicates were performed in Figure 6e . For all of the figures, results are shown as means and error bars defined as s.e.m. **P < 0.01, *P < 0.05 were considered significant, while P > 0.05 was considered nonsignificant. T-values and degrees of freedom for t-tests were as follows: For Figure 4b ,c, where functional enrichment analysis of GO and KEGG terms was performed, Fisher's exact test was used. P < 0.01 was considered significant. The analysis was performed using Perseus software platform (version 1.5.0.15) 59 .
Statistical analysis. To determine statistical significance in
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